Evidence map›Paper›PMID 32670896›Full record

ArticleFrontiers in cellular and infection microbiology2020

Characterization of a Sulfhydryl Oxidase From

Wenqi Zheng, Fei Liu, Feng Du, Fan Yang, Xu Kou, Yiwen He, Hui Feng, Qi Fan, Enjie Luo, Hui Min and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Immunogenicity and transmission-blocking potential of quiescin sulfhydryl oxidase inFrontiers in cellular and infection microbiology · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Wenqi ZhengDepartment of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Fei LiuDepartment of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Feng DuDepartment of Pathogen Biology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Fan YangDepartment of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Xu KouDepartment of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Yiwen HeDepartment of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Hui FengDepartment of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Qi FanDalian Institute of Biotechnology, Dalian, China.
Enjie LuoDepartment of Pathogen Biology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Hui MinDepartment of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
Jun MiaoDepartment of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, United States.
Liwang CuiDepartment of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, United States.
Yaming CaoDepartment of Immunology, College of Basic Medical Sciences, China Medical University, Shenyang, China.
China Medical University · CNUniversity of South Florida · USInner Mongolia Medical University · CN

Funding

Southeast Asia Malaria Research CenterU19AI089672 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI CUI, LIWANG · 2010 to 2023
$28.9M
Antigen discovery for transmission-blocking vaccines in Plasmodium vivaxR01AI150533 · NIAID · CHINA MEDICAL UNIVERSITY · PI CAO, YAMING · 2020 to 2024
$677k
Transmission blocking vaccine study in Plasmodium vivaxR01AI099611 · NIAID · CHINA MEDICAL UNIVERSITY · PI CAO, YAMING · 2012 to 2016
$648k
NIAID NIH HHS R01 AI099611NIAID NIH HHS R01 AI150533NIAID NIH HHS U19 AI089672
6 · The paper itself

Abstract

Quiescin sulfhydryl oxidase (QSOX), present in a wide variety of eukaryotic species, catalyzes the insertion of disulfide bonds into unfolded, reduced proteins. Here we characterized the QSOX protein from the rodent malaria parasite

Indexed as

MalariaParasitesAnimalsMaleMiceOocystsOxidoreductasesOxidoreductases Acting on Sulfur Group DonorsPlasmodium bergheiOxidoreductasesOxidoreductases Acting on Sulfur Group DonorsmalariaPlasmodium bergheiquiescin sulfhydryl oxidasesexual developmenttransmission-blocking vaccine

Identifiers

PMID32670896
PMCPMC7332561
OpenAlexW3034561324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.